Abbott Laboratories (LON:0Q15)
London flag London · Delayed Price · Currency is GBP · Price in USD
128.45
-1.21 (-0.93%)
At close: Apr 25, 2025

Abbott Laboratories Statistics

Total Valuation

LON:0Q15 has a market cap or net worth of GBP 167.89 billion. The enterprise value is 173.56 billion.

Market Cap 167.89B
Enterprise Value 173.56B

Important Dates

The last earnings date was Wednesday, April 16, 2025.

Earnings Date Apr 16, 2025
Ex-Dividend Date Apr 15, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.07%
Shares Change (QoQ) +0.06%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.72B

Valuation Ratios

The trailing PE ratio is 16.13.

PE Ratio 16.13
Forward PE n/a
PS Ratio 5.12
PB Ratio 4.53
P/TBV Ratio 12.11
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 16.67
EV / Sales 5.46
EV / EBITDA 20.32
EV / EBIT 29.67
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.32
Debt / EBITDA 1.34
Debt / FCF n/a
Interest Coverage 14.23

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 8.32%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 287,490
Profits Per Employee 91,324
Employee Count 114,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +20.16% in the last 52 weeks. The beta is 0.66, so LON:0Q15's price volatility has been lower than the market average.

Beta (5Y) 0.66
52-Week Price Change +20.16%
50-Day Moving Average 130.70
200-Day Moving Average 118.55
Relative Strength Index (RSI) 48.85
Average Volume (20 Days) 5,457

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.99

Income Statement

In the last 12 months, LON:0Q15 had revenue of GBP 32.77 billion and earned 10.41 billion in profits. Earnings per share was 5.96.

Revenue 32.77B
Gross Profit 18.33B
Operating Income 6.03B
Pretax Income 5.69B
Net Income 10.41B
EBITDA 8.52B
EBIT 6.03B
Earnings Per Share (EPS) 5.96
Full Income Statement

Balance Sheet

The company has 6.17 billion in cash and 11.82 billion in debt, giving a net cash position of -5.66 billion.

Cash & Cash Equivalents 6.17B
Total Debt 11.82B
Net Cash -5.66B
Net Cash Per Share n/a
Equity (Book Value) 37.07B
Book Value Per Share 21.30
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 55.92%, with operating and profit margins of 18.39% and 31.89%.

Gross Margin 55.92%
Operating Margin 18.39%
Pretax Margin 17.37%
Profit Margin 31.89%
EBITDA Margin 25.98%
EBIT Margin 18.39%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.77, which amounts to a dividend yield of 1.38%.

Dividend Per Share 1.77
Dividend Yield 1.38%
Dividend Growth (YoY) 5.35%
Years of Dividend Growth 6
Payout Ratio n/a
Buyback Yield 0.07%
Shareholder Yield 1.45%
Earnings Yield 6.20%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on June 1, 1998. It was a forward split with a ratio of 2.

Last Split Date Jun 1, 1998
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score n/a